miR-193b acts as a cisplatin sensitizer via the caspase-3-dependent pathway in HCC chemotherapy (Q38872361)
Jump to navigation
Jump to search
scientific article published on 19 May 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | miR-193b acts as a cisplatin sensitizer via the caspase-3-dependent pathway in HCC chemotherapy |
scientific article published on 19 May 2015 |
Statements
1 reference
miR-193b acts as a cisplatin sensitizer via the caspase-3-dependent pathway in HCC chemotherapy (English)
1 reference
Wenjun Yin
1 reference
Yuehua Nie
1 reference
Zhiwei Zhang
1 reference
Liming Xie
1 reference
Xiusheng He
1 reference
19 May 2015
1 reference
1 reference
34
1 reference
1
1 reference
368-374
1 reference
Identifiers
1 reference
1 reference